XRAY
DENTSPLY SIRONA Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$11.36
−0.63%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 3.6B | 3.7B | 3.8B | 4.0B | 3.9B |
| Cost of Revenue | 1.8B | 1.8B | 1.8B | 1.9B | 1.8B |
| Gross Profit | 1.8B | 1.8B | 2.0B | 2.1B | 2.1B |
| Operating Expenses | |||||
| R&D Expense | 166.0M | 150.0M | 165.0M | 184.0M | 174.0M |
| SG&A Expense | 1.5B | 1.4B | 1.6B | 1.6B | 1.6B |
| General & Admin Expense | 711.0M | — | — | 1.6B | 1.6B |
| Selling & Marketing Expense | — | — | — | (7.0M) | (7.0M) |
| Other Expenses | (246.0M) | — | 1.1B | 374.0M | 1.3B |
| Total Operating Expenses | 1.4B | 1.6B | 2.8B | 2.2B | 3.1B |
| Cost and Expenses | 3.2B | 3.4B | 4.7B | 4.0B | 4.9B |
| Operating Income (EBIT) | 426.0M | 252.0M | (879.0M) | (85.0M) | (937.0M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 91.0M | 88.0M | 69.0M | 81.0M | 65.0M |
| Net Interest Income | (91.0M) | (88.0M) | (69.0M) | (81.0M) | (65.0M) |
| Other Non-Op Income/Expense | (773.0M) | (738.0M) | (57.0M) | (90.0M) | (118.0M) |
| Non-Operating Income (excl Interest) | 682.0M | 650.0M | (12.0M) | 9.0M | 53.0M |
| EBT (Pre-Tax Income) | (347.0M) | (486.0M) | (936.0M) | (175.0M) | (1.1B) |
| Income Tax Expense | 200.0M | 112.0M | (26.0M) | (43.0M) | (105.0M) |
| Bottom Line | |||||
| Net Income | (546.0M) | (598.0M) | (910.0M) | (132.0M) | (950.0M) |
| Earnings from Cont. Ops | (547.0M) | (598.0M) | (910.0M) | (132.0M) | (950.0M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (546.0M) | (598.0M) | (910.0M) | (132.0M) | (950.0M) |
| Per Share | |||||
| Basic EPS | ($2.74) | ($3.00) | ($4.48) | ($0.62) | ($4.41) |
| Diluted EPS | ($2.74) | ($3.00) | ($4.48) | ($0.62) | ($4.41) |
| Revenue Per Share | $18.24 | $18.46 | $18.67 | $18.70 | $18.20 |
| Shares | |||||
| Basic Shares Outstanding | 199.7M | 199.4M | 203.2M | 212.0M | 215.5M |
| Diluted Shares Outstanding | 200.5M | 199.4M | 203.2M | 212.0M | 215.5M |
| Profitability Metrics | |||||
| EBITDA | 172.0M | (46.0M) | (518.0M) | 249.0M | (662.0M) |
| D&A | 428.0M | 352.0M | 349.0M | 343.0M | 328.0M |
| EBIT | (256.0M) | (398.0M) | (867.0M) | (94.0M) | (990.0M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026